Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06430632 · ClinicalTrials.gov registry record · NA

Early Robotic Gait Training After Stroke

A NA study of Stroke, sponsored by Baylor Research Institute.

Recruiting
Registry status
NA
Development phase
54
Enrollment target
1
Study location

NCT06430632: Recruiting NA study of Stroke, sponsored by Baylor Research Institute.

NCT06430632 is a NA study of Stroke that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 54 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06430632, a NA study of Stroke, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
NA
Development phase
54 participants
Enrollment target
1
Study location

Study Summary

The ERA Stroke project will compare the effects of robotic gait training (RGT) and usual care (UC) gait training in patients in the subacute phase of stroke recovery undergoing inpatient rehabilitation at the Baylor Scott \& White Institute for Rehabilitation (BSWIR).

Primary Outcome

The 10MWT assesses gait speed over a short duration. Gait speed (m/s) is correlated with ability to mobilize in the community, capacity to perform activities of daily living, and risk of falls, re-hospitalization, and cognitive decline. The 10MWT can be used to categorize individuals according to their ambulatory ability: household ambulators (\<0.4 m/s), limited community ambulators (0.4 to 0.8 m/s), and community ambulators (\>0.8 m/s). Score changes \>0.16 m/s exceed the MCID. Normal gait spe

Conditions Studied

Interventions

  • DEVICE Robotic Gait Training
  • OTHER Usual Care Gait Training

Study Locations (1)

Texas

  • Baylor Scott & White Institute for Rehabilitation - Dallas

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2024-03-01
Est. Completion 2026-12
Phase NA
Baylor Research Institute

180 total trials

What NCT06430632 shows while recruiting

NCT06430632 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Robotic Gait Training is the first listed.

NCT06430632 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06430632 about?

NCT06430632 is a clinical study titled "Early Robotic Gait Training After Stroke". The ERA Stroke project will compare the effects of robotic gait training (RGT) and usual care (UC) gait training in patients in the subacute phase of stroke recovery undergoing inpatient rehabilitation at the Baylor Scott \& White Institute for Rehabilitation (BSWIR).

What is the current status of trial NCT06430632?

This trial is currently recruiting. It is a NA study. The enrollment target is 54 participants. The study started on 2024-03-01. Estimated completion is 2026-12.

What conditions does trial NCT06430632 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06430632?

The interventions under investigation include: Robotic Gait Training (DEVICE), Usual Care Gait Training (OTHER).

Who is sponsoring clinical trial NCT06430632?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06430632 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06430632's enrollment target sits among peer trials

54 228th of 454 higher than 226 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06430632, the US trial registry maintained by the National Library of Medicine. NCT06430632 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.